Interleukin-6 (IL-6): A possible neuromodulator induced by neuronal activity

Neuroscientist

Volumn 8, Issue 3, 2002, Pages 268-275

  Jüttler, Eric ^a   Tarabin, Victoria ^a   Schwaninger, Markus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cerebral ischemia; Depression; Fever; Interleukin 6; Membrane depolarization; Neuroprotection

Indexed keywords

EXCITATORY AMINO ACID; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

BRAIN FUNCTION; CELL MEMBRANE DEPOLARIZATION; GLIA CELL; NERVE CELL; NEUROMODULATION; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVIEW;

EID: 0036113566     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/1073858402008003012     Document Type: Review

References (60)

1. Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain
2. Interleukin-6 in biology and medicine
3. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain
4. IL-6 deficiency leads to increased emotionality in mice: Evidence in transgenic mice carrying a null mutation for IL-6
5. Interleukin-6 enhances expression of adenosine A(1) receptor mRNA and signaling in cultured rat cortical astrocytes and brain slices
6. Role of IL-6 in cytokine-induced sickness behavior. A study with IL-6 deficient mice
7. Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin c fragment
8. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes
9. The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice
10. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6
11. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways
12. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1β: A study on IL-6-deficient mice
13. Depression, stress and immunological activation: The role of cytokines in depressive disorders
14. Temperature modulation (hypothermic and hyperthermic conditions) and its influence on histological and behavioral outcomes following cerebral ischemia
15. Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex
16. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus
17. IL-6- deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
18. Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats
19. Interleukin-6 (IL-6) - A molecule with both beneficial and destructive potentials
20. Requirement for BDNF in activity-dependent survival of cortical neurons
21. The relationship between neuronal survival and regeneration
22. Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid
23. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury
24. Interleukin-6-type cytokine signalling through the gp130/ Jak/STAT pathway
25. Cytokines promote the survival of mouse cranial sensory neurones at different developmental stages
26. The soluble interleukin 6 receptor: Mechanisms of production and implications in disease
27. Regulation of corticotropin-releasing factor (CRF) messenger ribonucleic acid and CRF peptide in the amygdala: Studies in primary amygdalar cultures
28. Role of Ca2+ channels in the ability of membrane depolarization to prevent neuronal death induced by trophic-factor deprivation: Evidence that levels of internal Ca2+ determine nerve growth factor dependence of sympathetic ganglion cells
29. Interleukin-6 protects rat PC12 cells from serum deprivation or chemotherapeutic agents through the phosphatidylinositol 3-kinase and STAT3 pathways
30. AM424: History of a novel drug candidate
31. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression
32. Interleukin-6 prevents ischemia-induced learning disabilities and neuronal and synaptic loss in gerbils
33. Neurotrophins and synaptic plasticity
34. Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons
35. Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease
36. Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons
37. Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation
38. Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons
39. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures
40. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures
41. Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons
42. Cytokine-associated emotional and cognitive disturbances in humans
43. Interleukin-6 mRNA expression by cortical neurons in culture: Evidence for neuronal sources of interleukin-6 production in the brain
44. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection
45. Induction of interleukin-6 by depolarization of neurons
46. NF-κB is activated and promotes cell death in focal cerebral ischemia
47. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain
48. Calmodulin is involved in membrane depolarization-mediated survival of motoneurons by phosphatidylinositol-3 kinase- and MAPK-independent pathways
49. Neuronal regulation of interleukin-6 secretion in murine spleen: Adrenergic and opioidergic control
50. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients
51. Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro
52. Expression of interleukin-6 is suppressed by inhibition of voltage-sensitive Na+/Ca2+ channels after cerebral ischemia
53. Immunohistochemical detection of leukemia inhibitory factor after focal cerebral ischemia in rats
54. Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats
55. The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK
56. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke
57. "Inflammatory" cytokines: Neuromodulators in normal brain?
58. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain
59. Sensory impairment and delayed regeneration of sensory axons in interleukin-6-deficient mice